Canadian Multicenter Chronic Total Occlusion Registry: Ten-Year Follow-Up Results of Chronic Total Occlusion Revascularization

医学 传统PCI 血运重建 经皮冠状动脉介入治疗 心脏病学 内科学 急性冠脉综合征 外科 动脉 心肌梗塞
作者
Bradley H. Strauss,Merril L. Knudtson,Asim N. Cheema,P. Diane Galbraith,Gabby Elbaz‐Greener,Wael Abuzeid,Kayley A. Henning,Feng Qiu,Harindra C. Wijeysundera
出处
期刊:Circulation-cardiovascular Interventions [Lippincott Williams & Wilkins]
卷期号:14 (12) 被引量:25
标识
DOI:10.1161/circinterventions.121.010546
摘要

Background: Chronic total occlusions (CTO) occur in nearly 20% of coronary angiograms. CTO revascularization, either by percutaneous coronary intervention (PCI) or coronary artery bypass grafting surgery (CABG), is infrequently performed, approximately one-third of cases. Long-term outcomes are unknown. The objective of the study was to determine whether early CTO revascularization of patients, either by CABG or PCI, was associated with improved clinical outcomes. Methods: One thousand six hundred twenty-four patients from the Canadian CTO registry were followed for at least 9.75 years. Revascularization was performed according to routine clinical practice. Patients were grouped according to CTO revascularization status (PCI or CABG of CTO vessel, CTO revasc) or no CTO revasc (medical therapy only, or PCI/CABG of non-CTO vessels only), within 3 months of initial angiogram. Patients were followed for mortality, revascularization procedures (PCI and CABG), and hospitalizations for acute coronary syndromes and heart failure. Results: Early CTO revasc was performed in 28.2% of patients (17.5% CABG, 10.7% PCI). The CTO revasc group was younger, with more males and generally fewer comorbidities. There was a significantly lower mortality probability at 10 years in the CTO revascularization group (22.7% [95% CI, 19.0%–26.9%]) compared with the no CTO revasc group (36.6% [95% CI, 33.8%–39.5%]). At 10 years, revascularization rates (14.0% versus 22.8%) and acute coronary syndrome hospitalization rates (10.0% versus 16.6%) were significantly lower in the CTO revasc group. Baseline-adjusted analysis showed CTO revasc was associated with significantly lower all-cause mortality (hazard ratio, 0.67 [95% CI, 0.54–0.84]). In both landmark and time varying analyses, association with lower mortality was particularly robust for CTO revascularization by CABG (hazard ratio 0.56 and 0.60, respectively), with a marginally significant result for PCI in the time varying analysis (hazard ratio 0.711 [95% CI, 0.51–0.998]). Conclusions: Early CTO revascularization was associated with significantly lower all-cause mortality, revascularization rates, and hospitalization for acute coronary syndrome at 10 years, and mainly driven by outcomes in patients with CABG.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
kuyi完成签到 ,获得积分10
2秒前
wangwang完成签到 ,获得积分10
3秒前
古今奇观完成签到 ,获得积分10
4秒前
Gino完成签到,获得积分0
6秒前
小丁同学应助一个小胖子采纳,获得10
6秒前
悟空完成签到 ,获得积分10
9秒前
10秒前
13秒前
14秒前
量子星尘发布了新的文献求助10
15秒前
你好完成签到,获得积分10
20秒前
小丁同学应助一个小胖子采纳,获得10
21秒前
优雅含莲完成签到 ,获得积分10
22秒前
xrkxrk完成签到 ,获得积分0
24秒前
桥豆麻袋完成签到,获得积分10
27秒前
livra1058完成签到,获得积分10
28秒前
yurunxintian完成签到,获得积分10
28秒前
纯真的德地完成签到 ,获得积分10
29秒前
Amon完成签到 ,获得积分10
31秒前
31秒前
blueskyzhi完成签到,获得积分10
32秒前
Gang完成签到,获得积分10
32秒前
小民完成签到 ,获得积分10
33秒前
小丁同学应助一个小胖子采纳,获得10
36秒前
缥缈的闭月完成签到,获得积分10
38秒前
量子星尘发布了新的文献求助10
39秒前
BK_201完成签到,获得积分10
40秒前
abiorz完成签到,获得积分0
41秒前
窗外是蔚蓝色完成签到,获得积分0
42秒前
高贵逍遥完成签到 ,获得积分10
46秒前
打打应助欣喜的嘉熙采纳,获得10
48秒前
凤兮完成签到 ,获得积分10
49秒前
fissh完成签到,获得积分10
50秒前
Noah完成签到 ,获得积分0
52秒前
小丁同学应助一个小胖子采纳,获得10
54秒前
54秒前
丘比特应助科研通管家采纳,获得10
54秒前
cctv18应助科研通管家采纳,获得10
54秒前
脑洞疼应助科研通管家采纳,获得30
54秒前
科研通AI2S应助科研通管家采纳,获得10
54秒前
高分求助中
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 2000
The Oxford Encyclopedia of the History of Modern Psychology 2000
Chinesen in Europa – Europäer in China: Journalisten, Spione, Studenten 1200
Deutsche in China 1920-1950 1200
Synthesis of 21-Thioalkanoic Acids of Corticosteroids 1000
Electron microscopy study of magnesium hydride (MgH2) for Hydrogen Storage 1000
Applied Survey Data Analysis (第三版, 2025) 850
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3883870
求助须知:如何正确求助?哪些是违规求助? 3426175
关于积分的说明 10747174
捐赠科研通 3150996
什么是DOI,文献DOI怎么找? 1739202
邀请新用户注册赠送积分活动 839633
科研通“疑难数据库(出版商)”最低求助积分说明 784734